O
DMRA

OrbiMed’s Damora Therapeutics DMRA Stock Holding History

OrbiMed’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,992
Closed -$665K – 124
2023
Q3 		$665K Sell
36,992
-116,377
-76% -$4.57M 0.01% 123
2023
Q2 		$9.66M Sell
153,369
-10,268
-6% -$559K 0.18% 88
2023
Q1 		$8.14M Hold
163,637
– – 0.16% 90
2022
Q4 		$4.7M Hold
163,637
– – 0.09% 95
2022
Q3 		$7.73K Hold
163,637
– – 0.14% 93
2022
Q2 		$7.08K Hold
163,637
– – 0.13% 102
2022
Q1 		$9M Hold
163,637
– – 0.15% 103
2021
Q4 		$12.4M Hold
163,637
– – 0.16% 110
2021
Q3 		$14.7M Hold
163,637
– – 0.16% 111
2021
Q2 		$20.7M Hold
163,637
– – 0.21% 98
2021
Q1 		$24.9M Hold
163,637
– – 0.23% 88
2020
Q4 		$51.2M Buy
+163,637
New +$60.9M 0.45% 62

Other funds holding DMRA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return